Trajan Scientific and Medical (Trajan) was pleased to sponsor the Australian Institute of Medical Scientists (AIMS) Medical Science Awards held in Queensland, Australia on 14 July 2016.
The awards recognized medical scientists, laboratory technologists, phlebotomists, young, regional/remote scientists, educations/workplace trainers, and graduates who demonstrated an outstanding contribution to medical science in the areas of professional commitment, excellence, service, research and innovation.
Trajan was the first corporate member of AIMS, supporting this diverse professional body covering various disciplines of medical science, including more than 23,000 medical diagnostic professionals across Australia.
Photo: Glen Lynch accepting the AIMS Queensland Trajan Medical Scientist of the Year Award 2016.
Photo: QLD Minister for Science, Innovation and the Digital Economy the Hon. Leeanne Enoch MP, QLD Minister for Health the Hon. Cameron Dick MP, and QLD Chief Scientist Dr Geoff Garrett AO with our award winners Ms Deborah Orr, Mr Wayne Pederick, Mr Glen Lynch, Dr Indu Singh, Mr Lloyd Magpayo and Ms Kathryn Eckersley. Accompanied by AIMS President Ms Robyn Wells, Chair of the AIMS Queensland Branch Ms Anne-Marie Christensen, Chair of the AIMS Tropical Divison, Dr Donna Rudd, members of the AIMS National Office staff, and Ms Alex Anderson, Regional Account Manager - Northern Region, Trajan Scientific and Medical.
Photo (L-R): Young Medical Scientist of the Year Ms Kathryn Eckersley, Medical Science Researcher of the Year Dr Indu Singh, Chair of the AIMS Queensland Branch Ms Anne-Marie Christensen, Ms Alex Anderson, Regional Account Manager - Northern Region, Trajan Scientific and Medical, and Laboratory Assistant of the Year Mr Lloyd Magpayo.
AIMS Event Photo Album on Facebook
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.
Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.